Skip to content

Effect of Exercise on Prevention of Weight Gain

Effect of Exercise on Prevention of Weight Gain

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00177502
Enrollment
294
Registered
2005-09-15
Start date
2003-01-31
Completion date
2006-12-31
Last updated
2005-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Weight Loss

Brief summary

The purpose of this study is to examine the dose-response of exercise on prevention of weight gain in overweight adults.

Interventions

BEHAVIORALbehavioral exercise intervention

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
University of Pittsburgh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

1. Female or Male 2. 18-55 years of age 3. BMI = 25-29.9 kg/m2 4. Ability to provide informed consent. 5. Ability to provide consent from their personal physician to participate in this study.

Exclusion criteria

1. Reporting regular exercise participation of at least 20 minutes per day on at least 3 days per week during the previous six months. (This study is designed to recruit relatively sedentary adults.) 2. Diabetes, hypothyroidism, or other medical conditions which would affect energy metabolism. 3. Women who are currently pregnant, pregnant within the previous six months, or planning on becoming pregnant within the next 12 months. (Pregnancy during initial screening will be based on self-report and will be included on the detailed medical history that is completed by subjects. However, this will be confirmed with the urine pregnancy test that will be conducted prior to the baseline DEXA.) 4. Non-medicated resting systolic blood pressure \>160 mmHg or non-medicated resting diastolic blood pressure \>100 mmHg, or taking medication that would affect blood pressure. 5. Taking medication that would affect resting heart rate or the heart rate response during exercise (e.g., beta blockade). 6. Arrhythmia on resting or exercise electrocardiogram that would indicate that vigorous exercise was contraindicated. 7. History of myocardial infarction or valvular disease. 8. History of orthopedic complications that would prevent optimal participation in the exercise component (e.g., heel spurs, severe arthritis).

Design outcomes

Primary

MeasureTime frame
body weight

Secondary

MeasureTime frame
fitness
physical activity
dietary intake
mediators

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 1, 2026